Financials
- Market Capitalization 180.5688 M
- Employee 184
- Founded 2004
- CEO Laura Niklason
- Website www.humacyte.com
- Headquarter Delaware, United States
- FIGI BBG00XPPT7S7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.36
売上高対価格比率
7.27
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 6963 | SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0258 USD | +1.57% | -0.77% | +158.00% | +1.18% | 344.84 M USD | ||
| 6971 | YDESW YD Bio Limited - Warrants | 0.4174 USD | +19.26% | +61.53% | +66.96% | -13.04% | 339.79 M USD | ||
| 7193 | ENGNW enGene Therapeutics Inc. - Warrants | 0.2300 USD | -7.67% | -22.09% | -34.27% | -66.99% | 122.59 M USD | ||
| 7209 | FBIOP Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock | 18.61 USD | +0.27% | +0.65% | -0.96% | +121.28% | 101.88 M USD |